BMPR2 Gene Pulmonary Hypertension Primary Type NGS Genetic DNA Test
Comprehensive Genetic Testing for Primary Pulmonary Hypertension
The BMPR2 Gene Pulmonary Hypertension Primary Type NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals at risk of developing primary pulmonary arterial hypertension (PAH). This sophisticated genetic analysis utilizes next-generation sequencing technology to detect mutations in the BMPR2 gene, which plays a critical role in regulating blood vessel development and function in the pulmonary arteries.
What Does This Test Measure?
This advanced genetic test specifically targets the BMPR2 (Bone Morphogenetic Protein Receptor Type 2) gene, which is responsible for encoding a receptor protein essential for proper blood vessel formation and maintenance in the lungs. The test identifies:
- Point mutations in the BMPR2 gene coding regions
- Small insertions and deletions affecting gene function
- Genetic variants associated with increased PAH risk
- Inheritance patterns of pulmonary hypertension predisposition
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Unexplained shortness of breath during routine activities
- Persistent fatigue and reduced exercise tolerance
- Chest pain or pressure without cardiac explanation
- Dizziness or fainting episodes
- Swelling in ankles, legs, or abdomen
- Family history of pulmonary hypertension
- Unexplained right heart failure symptoms
Key Benefits of Genetic Testing
Undergoing the BMPR2 gene test provides numerous advantages:
- Early Detection: Identify genetic predisposition before symptoms develop
- Personalized Treatment: Tailor medical management based on genetic profile
- Family Planning: Make informed decisions about genetic inheritance
- Proactive Monitoring: Implement early intervention strategies
- Peace of Mind: Reduce uncertainty about genetic risk factors
Understanding Your Test Results
Your genetic test results will fall into one of several categories:
- Positive Result: Indicates the presence of a BMPR2 gene mutation associated with increased PAH risk. This requires consultation with a genetic counselor and pulmonary specialist for comprehensive management planning.
- Negative Result: No known disease-causing mutations detected, though continued monitoring may be recommended based on clinical presentation.
- Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact, requiring ongoing research and periodic re-evaluation.
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have conveniently located testing centers across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality genetic testing services nationwide.
Take Control of Your Health Today
Don’t let uncertainty about genetic risk factors compromise your health and peace of mind. Our comprehensive BMPR2 gene testing provides the clarity you need to make informed healthcare decisions. With rapid turnaround times of 3-4 weeks and multiple sample collection options including blood, extracted DNA, or blood spots on FTA cards, getting tested has never been more convenient.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your BMPR2 Gene Pulmonary Hypertension Primary Type NGS Genetic DNA Test. Take the first step toward understanding your genetic health and securing your future wellbeing.
